Lidothol Patch
Product Images NDC 80425-0385

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lidothol (NDC 80425-0385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidothol Patch #15 (Lidothol Patch 80425 0385 01)

LIDOTHOL patch packaging label showing the product name LIDOTHOL, formulation with lidocaine and menthol, and dosage form as patch. The label includes lot number, expiration date 1/1/2025, barcode, storage instructions at 20°-25°C (68°-77°F), and is marked Rx Only. The labeler is Advanced Rx Pharmacy of Tennessee, LLC, located in Nashville, TN. The NDC is 80425-0385-01.*

FDA Label Image

Fig1 (Fig1)

A line graph depicting plasma lidocaine concentration (ng/mL) over a 72-hour period. The chart shows three distinct peaks in lidocaine levels, each rising sharply and then gradually declining before the next peak. The x-axis represents time in hours, and the y-axis represents plasma lidocaine concentration.*

FDA Label Image

Lidocaine (Lidocaine)

Chemical structure diagram of the lidocaine molecule, showing its aromatic ring, amide, and diethylamine groups. This structure represents the active ingredient lidocaine in the LIDOTHOL topical patch.*

FDA Label Image

Menthol (Menthol)

Chemical structure diagram of an active ingredient associated with the product LIDOTHOL, showing a cyclohexane ring with hydroxyl and methyl substituents.*

FDA Label Image

Mentholpath (Pathway)

Illustration showing the proposed metabolic pathway of menthol, depicting chemical structures of menthol and its metabolites such as para-Menthane-3,7-diol, para-Menthane-3,9-diol, para-Menthane-3,8-diol, and related carboxylic acid derivatives. Arrows indicate metabolic transformations, enterohepatic circulation, and excretion routes to urine and feces.*

FDA Label Image

Table1 (Table1)

A data table titled "Absorption of Lidocaine from Lidocaine 5% Patch" presenting pharmacokinetic information in normal volunteers after 12-hour wear. It includes columns for number of patches applied, application site, area covered, dose absorbed (mg), peak concentration (Cmax in µg/mL), and time to peak concentration (Tmax in hours).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.